n-3 polyunsaturated fatty acids and cardiovascular diseases

被引:102
|
作者
Nordoy, A
Marchioli, R
Arnesen, H
Videbæk, J
机构
[1] Univ Tromso, Dept Med, Tromso, Norway
[2] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy
[3] Univ Hosp, Ulleval Hosp, Dept Cardiol, Oslo, Norway
[4] Heart Assoc, Dept Res, Copenhagen K, Denmark
关键词
D O I
10.1007/s11745-001-0695-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An expert round table discussion on the relationship between intake of n-3 polyunsaturated fatty acids (PUFA) mainly of marine sources and coronary heart disease at the 34th Annual Scientific Meeting of European Society for Clinical Investigation came to the following conclusions: 1. Consumption of 1-2 fish meals/wk is associated with reduced coronary heart disease (CHD) mortality. 2. Patients who have experienced myocardial infarction have decreased risk of total, cardiovascular, coronary, and sudden death by drug treatment with 1 g/d of ethylesters of n-3 PUFA, mainly as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The effect is present irrespective of high or low traditional fish intake or simultaneous intake of other drugs for secondary CHD prevention. n-3 PUFA may also be given as fatty fish or triglyceride concentrates. 3. Patients who have experienced coronary artery bypass surgery with venous grafts may reduce graft occlusion rates by administration of 4 g/d of n-3 PUFA. 4. Patients with moderate hypertension may reduce blood pressure by administration of 4 g/d of n-3 PUFA. 5. After heart transplantation, 4 g/d of n-3 PUFA may protect against development of hypertension. 6. Patients with dyslipidemia and or postprandial hyperlipemia may reduce their coronary risk profile by administration of 1-4 g/d of marine n-3 PUFA. The combination with statins seems to be a potent alternative in these patients. 7. There is growing evidence that daily intake of up to 1 energy% of nutrients from plant n-3 PUFA (alpha-linolenic acid) may decrease the risk for myocardial infarction and death in patients with CHD. This paper summarizes the conclusions of an expert panel on the relationship between n-3 PUFA and CHD. The objectives for the experts were to formulate scientifically sound conclusions on the effects of fish in the diet and the administration of marine n-3 PUFA, mainly eicosapentaen.oic acid (EPA, 20.5n-3) and docosahexaenoic acid (DHA, 22:6n-3), and eventually of plant n-3 PUFA, alpha-linolenic acid (ALA, 18:3n-3), on primary and secondary prevention of CHID. Fish in the diet should be considered as part of a healthy diet low in saturated fats for everybody, whereas additional administration of n-3 PUFA concentrates could be given to specific groups of patients. This workshop was organized on the basis of questions sent to the participants beforehand, on brief introductions by the participants, and finally on discussion and analysis by a group of -40 international scientists in the fields of nutrition, cardiology, epidemiology, lipidology, and thrombosis.
引用
收藏
页码:S127 / S129
页数:3
相关论文
共 50 条
  • [31] Long Chain n-3 Polyunsaturated Fatty Acids in the Prevention of Allergic and Cardiovascular Disease
    van den Elsen, Lieke
    Garssen, Johan
    Willemsen, Linette
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (16) : 2375 - 2392
  • [32] Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health
    Siddiqui, Rafat A.
    Harvey, Kevin A.
    Zaloga, Galy P.
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2008, 19 (07): : 417 - 437
  • [33] The Role of Long-ChainedMarine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease
    Aarsetoey, Hildegunn
    Grundt, Heidi
    Nygaard, Ottar
    Nilsen, DennisW. T.
    CARDIOLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [34] Association of dietary n-3 polyunsaturated fatty acids with breast cancer risk: Serial mediating roles of erythrocyte n-3 polyunsaturated fatty acids
    Zhang, Zhuolin
    Jiang, Yiling
    Li, Xue
    Shi, Dandan
    Ma, Ting
    Zhou, Ruolin
    Zhang, Caixia
    FRONTIERS IN NUTRITION, 2022, 9
  • [35] Dietary n-3 and n-6 fatty acids: are there 'bad' polyunsaturated fatty acids?
    Deckelbaum, Richard J.
    Calder, Philip C.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (02): : 123 - 124
  • [36] n-3 fatty acids and cardiovascular disease
    Grundt, Heidi
    Nilsen, Dennis W. T.
    HAEMATOLOGICA, 2008, 93 (06) : 807 - 812
  • [37] n-3 Fatty Acids and Cardiovascular Events
    Heazlewood, Vernon J.
    Ahmed, Jamil
    Bazdar, Salih
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09): : 881 - 881
  • [38] n-3 Fatty Acids in Cardiovascular Disease
    Swedberg, Karl
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12): : 1159 - 1159
  • [39] n-3 fatty acids and cardiovascular disease
    Breslow, Jan L.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (06): : 1477S - 1482S
  • [40] n-3 fatty acids and cardiovascular disease
    Nilsen, DW
    Harris, WS
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 79 (01): : 166 - 166